Today I participated in the 2026 Walk to End Alzheimer's at the @oregonzoo.bsky.social with @alzassociation.bsky.social
#EndAlz #WalkToEndAlzheimers
#EndAlz #WalkToEndAlzheimers
October 10, 2026 at 5:11 PM
Today I participated in the 2026 Walk to End Alzheimer's at the @oregonzoo.bsky.social with @alzassociation.bsky.social
#EndAlz #WalkToEndAlzheimers
#EndAlz #WalkToEndAlzheimers
The momentum is building. 💜 Over 70 Walk to End Alzheimer’s events brought communities together from coast to coast this weekend. Thank you to everyone who joined us! Over 215 Walks are still to come. Register today: alz.org/walk #ENDALZ
October 13, 2026 at 1:20 PM
The momentum is building. 💜 Over 70 Walk to End Alzheimer’s events brought communities together from coast to coast this weekend. Thank you to everyone who joined us! Over 215 Walks are still to come. Register today: alz.org/walk #ENDALZ
Final hours: Our Autumn 2X Match ends at midnight. Give now and your gift can go 2X as far for families facing Alzheimer's. bit.ly/47P3bTu #ENDALZ
October 12, 2026 at 2:41 PM
Final hours: Our Autumn 2X Match ends at midnight. Give now and your gift can go 2X as far for families facing Alzheimer's. bit.ly/47P3bTu #ENDALZ
More than 1 in 10 people in Baltimore are touched by Alzheimer's disease, and together we can change that. Sign up for the Walk to End Alzheimer's at act.alz.org/baltimore. #Walk2EndAlz #ENDALZ
WBAL-TV 11 and 98 Rock are proud to be the official media partners.
WBAL-TV 11 and 98 Rock are proud to be the official media partners.
October 15, 2026 at 2:33 PM
More than 1 in 10 people in Baltimore are touched by Alzheimer's disease, and together we can change that. Sign up for the Walk to End Alzheimer's at act.alz.org/baltimore. #Walk2EndAlz #ENDALZ
WBAL-TV 11 and 98 Rock are proud to be the official media partners.
WBAL-TV 11 and 98 Rock are proud to be the official media partners.
In the fight against Alzheimer’s, now matters more than ever. Now is the time for action. Start or join a #Walk2EndAlz team at alz.org/walk. #ENDALZ
October 14, 2026 at 10:50 PM
In the fight against Alzheimer’s, now matters more than ever. Now is the time for action. Start or join a #Walk2EndAlz team at alz.org/walk. #ENDALZ
Caton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
October 10, 2026 at 10:59 PM
Caton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
Ending soon: Only days left to make 2X the impact. Every gift to our Autumn 2X Match through Oct. 12 goes twice as far for research and care for families facing Alzheimer's. Give now: bit.ly/4y547hb #ENDALZ
October 10, 2026 at 6:00 PM
Ending soon: Only days left to make 2X the impact. Every gift to our Autumn 2X Match through Oct. 12 goes twice as far for research and care for families facing Alzheimer's. Give now: bit.ly/4y547hb #ENDALZ
Thank you @liccardo.house.gov for taking the time to meet with our #ENDALZ advocates today! We appreciate you considering joining the bipartisan effort and adding your name as a cosponsor of the #ASAPAct which will clear the way for blood biomarker screening tests for Alzheimer's.
October 15, 2026 at 4:17 PM
Thank you @liccardo.house.gov for taking the time to meet with our #ENDALZ advocates today! We appreciate you considering joining the bipartisan effort and adding your name as a cosponsor of the #ASAPAct which will clear the way for blood biomarker screening tests for Alzheimer's.
Caton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
October 10, 2026 at 10:59 PM
Caton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
New clinical trial
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
The goal of this observational study is to study whether major surgery is linked to changes in the brain that are typical of Alzheimer's disease. The study is a prospective observational study that will be carried out in Uppsala University Hospital. Adults aged 55-75 years who...
brain-regeneration.com
October 14, 2026 at 7:00 AM
New clinical trial
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Sigma Kappa has surpassed $20 million in support for the fight to end Alzheimer's! 💜 Read one @SigmaKappaNHQ sister's story behind the milestone: https://bit.ly/473k90f #Walk2EndAlz #ENDALZ
October 7, 2026 at 10:50 PM
Sigma Kappa has surpassed $20 million in support for the fight to end Alzheimer's! 💜 Read one @SigmaKappaNHQ sister's story behind the milestone: https://bit.ly/473k90f #Walk2EndAlz #ENDALZ
It's #DAFDay! Recommend a grant from your donor-advised fund to help fuel Alzheimer's research and provide care and support to millions of families. Give in just a few clicks: bit.ly/4hPayii #ENDALZ
October 8, 2026 at 10:19 PM
It's #DAFDay! Recommend a grant from your donor-advised fund to help fuel Alzheimer's research and provide care and support to millions of families. Give in just a few clicks: bit.ly/4hPayii #ENDALZ
New clinical trial
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
This prospective, longitudinal observational cohort study will examine clinical, cognitive, blood-based, and neuroimaging features across the cognitive continuum. It will also assess whether these measures can distinguish disease stages and predict progression from mild cognit...
brain-regeneration.com
October 15, 2026 at 5:50 PM
New clinical trial
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
The project aims to develop a gamified medical yoga intervention through co-design with patients with cancer and key stakeholders, ensuring alignment with user needs and requirements. The first objective is to identify user and stakeholder needs, preferences, and requirements ...
brain-regeneration.com
October 15, 2026 at 7:00 AM
New clinical trial
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
VIZAMYL (flutemetamol F 18 injection) is a drug used during Positron Emission Tomography (PET) brain scans. It helps doctors detect the presence of amyloid protein, which is associated with Alzheimer's disease and other conditions affecting memory or thinking. A new formulatio...
brain-regeneration.com
October 14, 2026 at 5:40 PM
New clinical trial
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
This prospective, multicenter open-label study will evaluate the long-term safety, tolerability, PK and PD of acoramidis administered on a background of stable heart failure therapy.
brain-regeneration.com
October 14, 2026 at 5:50 PM
New clinical trial
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
This is a prospective, observational cohort study. The primary objective is to characterize the clinical features and mechanisms of behavioral and psychological symptoms of dementia (BPSD) in patients with probable Alzheimer's disease (AD) who are plasma p-Tau217 negative, and...
brain-regeneration.com
October 15, 2026 at 5:40 PM
New clinical trial
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias. HomeCare is an internet-connected medication management...
brain-regeneration.com
October 13, 2026 at 5:40 PM
New clinical trial
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Basey Insurance is supporting Walk to End Alzheimer’s again in 2026!
Every dollar raised supports the Alzheimer's Association's efforts to provide support to all facing Alzheimer's, accelerate research toward a cure.
Help us #ENDALZ with a donation?
zurl.co/9DuNS
Every dollar raised supports the Alzheimer's Association's efforts to provide support to all facing Alzheimer's, accelerate research toward a cure.
Help us #ENDALZ with a donation?
zurl.co/9DuNS
October 9, 2026 at 3:26 PM
Basey Insurance is supporting Walk to End Alzheimer’s again in 2026!
Every dollar raised supports the Alzheimer's Association's efforts to provide support to all facing Alzheimer's, accelerate research toward a cure.
Help us #ENDALZ with a donation?
zurl.co/9DuNS
Every dollar raised supports the Alzheimer's Association's efforts to provide support to all facing Alzheimer's, accelerate research toward a cure.
Help us #ENDALZ with a donation?
zurl.co/9DuNS
New clinical trial
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
The treatment of dementias of neurodegenerative origin is currently limited to symptomatic drugs that are unable to interfere with the underlying mechanisms of neurodegeneration, as the pathological processes leading to dementia begin decades before the onset of clinical sympt...
brain-regeneration.com
October 13, 2026 at 5:50 PM
New clinical trial
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
October 9, 2026 at 2:21 AM
Colin is a testament to the importance of early screening.
@repbradsherman.bsky.social, please tune in to hear from constituents Colin and Joanne of Sherman Oaks on the urgency of passing the #ASAPAct to secure Alzheimer's blood screening tests for Californians. #ENDALZ 🧠💜
@repbradsherman.bsky.social, please tune in to hear from constituents Colin and Joanne of Sherman Oaks on the urgency of passing the #ASAPAct to secure Alzheimer's blood screening tests for Californians. #ENDALZ 🧠💜
October 9, 2026 at 6:02 PM
Colin is a testament to the importance of early screening.
@repbradsherman.bsky.social, please tune in to hear from constituents Colin and Joanne of Sherman Oaks on the urgency of passing the #ASAPAct to secure Alzheimer's blood screening tests for Californians. #ENDALZ 🧠💜
@repbradsherman.bsky.social, please tune in to hear from constituents Colin and Joanne of Sherman Oaks on the urgency of passing the #ASAPAct to secure Alzheimer's blood screening tests for Californians. #ENDALZ 🧠💜
New clinical trial
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
Family caregivers of people living with dementia are at high risk of poor health when caregiving for their loved one. Peer Support for Family Caregivers of Older Adults Living with Dementia (Pair 2 Care©) is a simple, nonjudgmental, flexible, and potentially scalable peer sup...
brain-regeneration.com
October 10, 2026 at 7:10 AM
New clinical trial
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
New clinical trial
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
The primary purpose of this study is to describe the incidence and severity of known adverse events, including amyloid-related imaging abnormalities (ARIA)-oedema/effusion (ARIA-E), ARIA-microhemorrhage and haemosiderin deposit (ARIA-H), intracerebral hemorrhage greater than 1...
brain-regeneration.com
October 10, 2026 at 7:00 AM
New clinical trial
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
#ClinicalTrials #AlzheimersDisease #EndAlz #Neurology